{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"137"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"133"}],"units":"Participants"}],"description":"Number of participants who self-reported continuous abstinence from their initial quit day (study day 14) to 6 Months","groups":[{"description":"Patients receive oral varenicline once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached.\n\nvarenicline: Given orally","id":"OG000","title":"Arm I"},{"description":"Patients receive oral varenicline placebo once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached.\n\nplacebo: Given orally","id":"OG001","title":"Arm II"},{"description":"Patients receive a nicotine patch, with doses tapering over time for a total of 26 weeks. Patients also receive nicotine gum to quell breakthrough urges. Patients may stop treatment when a comfortable level of smoking abstinence is reached.\n\nnicotine: Given transdermally and orally","id":"OG002","title":"Arm III"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"6-Months","title":"Rates of Smoking Cessation Continuous From First Quit Day to 6 Months","type":"PRIMARY","unitOfMeasure":"participants"}